Skip to main content
. Author manuscript; available in PMC: 2025 Apr 1.
Published in final edited form as: Eur J Gastroenterol Hepatol. 2024 Feb 28;36(4):452–468. doi: 10.1097/MEG.0000000000002712

Table 2:

Sequential Cox Regression Analysis Using Donor Sex as a Prognostic Risk Factor for All-Cause Mortality and Graft Failure in Liver Transplant Recipients with Primary Sclerosing Cholangitis

Male vs Female Donor
(A) All-Cause Mortality (B) Graft Failure
Incidence Rates per 1000 Person-Years Incidence Rates per 1000 Person-Years
Male 32.38 (28.73 - 36.36) Male 6.57 (4.97 - 8.52)
Female 35.18 (30.76 - 40.04) Female 10.98 (8.56 - 13.88)
Raw Incidence Raw Incidence
Male 221 Male 69
Female 276 Female 56
Sequential Cox Regression Analysis Sequential Cox Regression Analysis
Model p-value aHR 95% CI Model p-value aHR 95% CI
1 0.33 0.92 (0.77 - 1.09) 1 0.004 ** 0.60 (0.42 - 0.85)
2 0.31 0.91 (0.76 - 1.09) 2 0.005 ** 0.60 (0.42 - 0.86)
3 0.31 0.91 (0.76 - 1.09) 3 0.004 ** 0.60 (0.42 - 0.85)
FM 0.47 0.94 (0.78 - 1.12) FM 0.01 * 0.63 (0.44 - 0.91)
Mismatch Subanalysis: Female (Sex Mismatch) vs Male Donor in Male Recipients
(A) All-Cause Mortality (B) Graft Failure
Incidence Rates per 1000 Person-Years Incidence Rates per 1000 Person-Years
Male 31.74 (27.55 - 36.37) Male 6.35 (4.54 - 8.63)
Female 36.90 (31.15 - 43.38) Female 12.56 (9.28 - 16.62)
Raw Incidence Raw Incidence
Male 141 Male 48
Female 200 Female 40
Sequential Cox Regression Analysis Sequential Cox Regression Analysis
Model p-value aHR 95% CI Model p-value aHR 95% CI
1 0.16 0.86 (0.69 - 1.06) 1 0.002 ** 0.51 (0.33 - 0.77)
2 0.14 0.85 (0.68 - 1.06) 2 0.002 ** 0.51 (0.33 - 0.78)
3 0.13 0.84 (0.68 - 1.05) 3 0.002 ** 0.50 (0.33 - 0.77)
FM 0.17 0.86 (0.69 - 1.07) FM 0.003 ** 0.51 (0.33 - 0.79)
Mismatch Subanalysis: Male (Sex Mismatch) vs Female Donor in Female Recipients
(A) All-Cause Mortality (B) Graft Failure
Incidence Rates per 1000 Person-Years Incidence Rates per 1000 Person-Years
Male 34.21 (27.05 - 42.64) Male 7.20 (4.12 - 11.67)
Female 32.51 (25.86 - 40.30) Female 8.53 (5.29 - 13.02)
Raw Incidence Raw Incidence
Male 80 Male 21
Female 76 Female 16
Sequential Cox Regression Analysis Sequential Cox Regression Analysis
Model p-value aHR 95% CI Model p-value aHR 95% CI
1 0.94 1.01 (0.74 - 1.39) 1 0.50 0.80 (0.41 - 1.54)
2 0.97 1.01 (0.73 - 1.39) 2 0.65 0.86 (0.44 - 1.67)
3 0.99 1.00 (0.72 - 1.38) 3 0.64 0.85 (0.44 - 1.67)
FM 0.72 1.06 (0.76 - 1.48) FM 0.99 1.00 (0.50 - 2.02)
*

p < 0.05

**

p < 0.01

***

p < 0.001

FM indicates Final Model

*

Model 1 includes VOI (variable of interest) and demographics; Model 2 includes Model 1 terms with the addition of comorbidities, and liver disease etiologies; Model 3 includes Model 2 terms with the addition of hepatic variables, MELD score, and liver laboratory markers; Model 4 includes Model 3 terms with the addition of donor demographics